Comparative report of rate of COVID19 infections in US and China

HEALTHCARE

Table of Contents
Background of the topic:.................................................................................................................3
1. Introduction..................................................................................................................................3
2. Objective......................................................................................................................................4
3. Methods.......................................................................................................................................5
3.1 Research Design....................................................................................................................5
3.2 Country selection...................................................................................................................5
4. Data collection.............................................................................................................................6
4.1 Data analysis..........................................................................................................................6
5. Results..........................................................................................................................................7
5.1 Evaluation and testing............................................................................................................7
5.1.1 Screening criteria............................................................................................................7
5.1.2 Confirmation of COVID 19............................................................................................9
5.2 Infection control.....................................................................................................................9
5.2.1 General outpatient guidance...........................................................................................9
5.2.2 Triage Protocols............................................................................................................10
5.3 Cost support.........................................................................................................................11
6. Community guidelines...............................................................................................................11
6.1 Prevent getting sick..............................................................................................................11
7. Conclusion.................................................................................................................................13
References......................................................................................................................................14

Topic: Comparative report of rate of COVID-
19 infections in US and China
Background of the topic:
In late January, a total emergency called COVID-19 was declared by the WHO a public health
emergency of international concern. In half a month, the program reached pandemic levels,
affecting more than 100 countries. The regulation and control of COVID-19 has been an
important issue on both a public and global scale due to emotional expansion in confirmed cases
around the world. Government regulations provide essential funding for networks, as they
monitor residents in the best possible way to protect themselves from COVID-19; however, they
also provide basic guidance to strategy representatives and medical care experts on how to best
move to reduce COVID-19 transmission. The point was to recognize the differences and
similarities between the rules of the network framework and the medical services provided by the
governments of two specific countries (US and China) and to examine the connection between
the deadlines in case management and the leadership / level of COVID-19 cases.
1. Introduction
The new COVID-19 program has raised serious concerns about the increase in mortality on the
planet. The main COVID-19 program was planned in the city of Wuhan, the capital of China's
Hubei region, at the end of December 2019 (Guan et etal., 2020). Two months after the fact, on
11 March 2020, the World Health Organization (WHO) assigned a pandemic to the COVID-19
incident and handed the regulations to the COVID-19 case to the office and council of the
shundn network. Across the world, approximately 3,506,577 fixed instances of COVID-19 have
been reported, this data added with more than 247,467 passages (Johns Hopkins University, May
3, 2020) (COVID-19 Dashboard from the Center for Systems Science and Engineering (CSSE))
at the Johns Hopkins University (JHU), 2020). The rapid spread of the disease highlights the
connected global well-being and the need to invest resources in global research efforts to study,
interpret and address the conditions of global well-being.

At the stage where China's main COVID-19 program was described, the Chinese government
introduced rules recommending keeping a social remote plantation open, living at home, and
freeing corrupt populations to keep the pandemic at bay. After a month, South Korea was
dispatched with the COVID-19 program. Starting activity by the two governments was solid in
attempting to forestall the spread of the infection, including both thorough testing for the illness
and ensuing reports. The COVID-19 reaction in China and South Korea stretched out the model
to different nations where COVID-19 was simply starting to develop. While it was not
satisfactory whether the exacting measures taken by China and South Korea could be changed or
modified by various nations, the multifaceted viewpoint of the infection all in all was
additionally supported by research on clinical administrations and organization input from
legislatures of various nations.
It reflects on factors which differ each country from each other such as capacities, risks, threats,
political and socio-economic challenges; additional to this various health care factor also make
difference on the way COVID impacts different countries. In any case, it is also crucial to look at
how different countries tended to deal with the Covid pandemic. Next, the rules of two specific
countries were looked at to examine the administration, frequency, and frequency of COVID-19
cases. Additionally, we looked at the relationship between regulatory deadlines and regulatory
frequency cycles of various countries.
2. Objective
The objective was to analyze government regulations on COVID-19 with two specific countries
(United States (US) and China). This included general population rules and the rules of medical
care specialists (clinical groups). The key point was to identify the differences and differences
between the national rules of nations and the rules of medical services and also to examine the
connection between the dates of issuance of the rules and the contamination / occurrence in
COVID-19 cases. This is huge because it looked at how different countries have responded to
COVID-19 and identified best practices. Similarly, this approach will allow us to see how the
medical services structure and boundaries of the strategy shape COVID-19 reactions and share
this data to inform COVID-19 reactions development.